Skip to main content
. Author manuscript; available in PMC: 2014 Mar 13.
Published in final edited form as: Immunol Res. 2013 Mar;55(0):34–47. doi: 10.1007/s12026-012-8348-9

Table 3.

Mimotopes for the immunodominant tumor antigen in CT26, AH1, identified using CT clone

Peptide/
Mimotope		 Amino acids % of mimotope cells that
cross-react with AH1		 % of AH1-specific T cells with TCR
that express the CDR3β motif		 % of tumor-free survival
60 days after challenge		 Reference
AH1 SPSYVYHQF 100 60 0 [53]
A5 SPSYAYHQF 60 45 90–100 [102]
F1A5 FPSYAYHQF 60 75 90–100 [104]
39 MNKYAYHML 30 40 50–60 [73]
15 MPKYAYHML 15 43 10–20 [73]
WMF SPTYAYWMF 10 10 0–10 [104]